Mouse Anti-Human EVA1

• Epithelial V-like antigen 1 (EVA1) is a protein whose expression is upregulated in hepatocellular carcinoma (HCC), and it is associated with poor prognosis and recurrence in HCC patients. Overexpression of EVA1 promotes various processes critical to cancer progression, including cell growth, invasion, and migration in vitro. Moreover, EVA1 has the ability to upregulate genes in the ERBB3-PI3K pathway, which is critical for cell survival, differentiation, and migration. These properties make EVA1 an important target for cancer research, particularly in liver cancer studies.

• • Host Species: Mouse
  • Target Species: Human
  • Conjugation: Unconjugated
  • Clonality: Monoclonal
  • Isotype: IgG
  • Form: Liquid

  Purification

  This antibody is purified via immunoaffinity chromatography, using an immunogen peptide derived from the EVA1protein, coupled to Sepharose 4B.

• •  
  • Storage Instructions: Store at -20°C upon receipt. Avoid repeated freeze-thaw cycles. The product is stable for several weeks at 4°C as an undiluted liquid.
  • Storage Buffer: Phosphate buffered saline (pH 7.4) with stabilizer and ≤0.09% sodium azide.

  For extended storage, aliquot and store at -20°C or below. Centrifuge if product is not completely clear after standing at room temperature.

This antibody is suitable for the following research applications:

• Western Blotting (WB)
• Immunohistochemistry (IHC-P, IHC-Frozen)
• Dot Blot
• Immunomicroscopy
• Immunofluorescence (IF)
• Flow Cytometry (FCM)

Recommended starting dilutions:

• Western Blotting: 3-5 µg/ml
• IHC (Paraffin/Frozen): 5-10 µg/ml
• Immunofluorescence: 5-10 µg/ml
• Flow Cytometry: 5-10 µg/ml

Note: Optimal dilutions should be determined by the end-user based on experimental conditions.